Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

23results about How to "Improve inflammatory response" patented technology

Atomizing agent containing stem cell exosome as well as preparation method and application of atomizing agent

The invention provides an atomizing agent containing stem cell exosomes as well as a preparation method and application of the atomizing agent, and belongs to the technical field of exosomes. Ferroferric oxide magnetic particles are prepared, the surfaces of the ferroferric oxide magnetic particles are modified through tannic acid, berberine and adriamycin are loaded, then the ferroferric oxide magnetic particles and the exosome secreted by adipose-derived mesenchymal stem cells are mixed, incubated and centrifuged, the mixture is added into normal saline, uniform ultrasonic dispersion is conducted, and the atomizing agent containing the stem cell exosome is prepared. The prepared atomizing agent containing the stem cell exosome is simple in preparation method and wide in raw material source, the prepared atomizing agent directly enters the lung through spray administration, the unique performance of magnetic targeting drug delivery is achieved, drugs are released in a targeted and fixed-point mode, the drug effect is improved, and the effects of efficiently promoting tumor cell apoptosis and resisting lung cancer and pneumonia are achieved.
Owner:BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD

Acne removing essence and preparation method thereof

The invention discloses an acne-removing essence and a preparation method thereof, and particularly relates to the technical field of skin care products, the acne-removing essence comprises the following components by mass: 0.5-5% of salicylic acid; 1%-5% of tartaric acid; 2%-6% of nicotinamide; 0.5%-2% of colloidal sulfur; 1.5%-3% of tea tree essential oil; 1%-2% of hyaluronic acid; 0.5%-1% of ceramide; 1%-3% of glycerol; 1%-2% of trehalose; the salicylic acid is used for penetrating into skin, helping to relieve dead skin cells, reducing inflammation and accelerating skin renewal; the tartaric acid is used for realizing a stripping effect, can remove aged cuticles on the surface of the skin and promote the generation of new cells, so that the problem of acnes is helped to be improved. The acne-removing essence prepared by the invention has a relatively good moisturizing effect, so that skin barrier can be well maintained, keratin metabolism is promoted, grease secretion is inhibited, acne is effectively prevented, inflammatory response of the acne is relieved, and the actual use effect of the acne-removing essence is relatively good.
Owner:GUANGZHOU YOUYANG COSMETICS CO LTD

Application of fermentation lactobacillus mucus A6-3 in preparation of helicobacter pylori inhibition product

PendingCN119033827Areduce colonizationImprove inflammatory responseAntibacterial agentsDigestive systemLactobacillusMedicine
The invention provides application of fermented lactobacillus mucus A6-3 in preparation of a product for inhibiting helicobacter pylori, and belongs to the technical field of biological medicine. The fermented lactobacillus mucus A6-3 can significantly reduce helicobacter pylori colonization and improve inflammatory response induced by helicobacter pylori. Meanwhile, the invention also provides an application of the lactobacillus mucus A6-3 combined with the licorice extract in preparation of a product for inhibiting helicobacter pylori, and the A6-3 combined with the licorice extract can significantly enhance inhibition of helicobacter pylori colonization and inflammatory response induced by helicobacter pylori by the A6-3. The invention provides thinking and theoretical basis for treatment of helicobacter pylori infection.
Owner:GUIZHOU MEDICAL UNIV

Application of baicalin in preparation of medicine for treating streptococcus agalactiae induced mastitis

The invention provides application of baicalin in preparation of a medicine for treating streptococcus agalactiae induced mastitis, and relates to the technical field of medicine. A mouse is selected as an animal model to research the intervention effect and mechanism of the baicalin on the streptococcus agalactiae induced mouse mastitis inflammatory response, and it is clear that the baicalin can play a role in protecting the mouse mammary gland by regulating and controlling an NLRP3 inflammatory small body pathway; a reference basis is provided for treating the cow mastitis caused by streptococcus agalactiae infection by applying the baicalin.
Owner:GUANGXI UNIV

1, 4-polyisoprene dispersion system, active pharmaceutical ingredient and application of 1, 4-polyisoprene dispersion system and active pharmaceutical ingredient

The invention provides a 1, 4-polyisoprene dispersion system, a pharmaceutical active component and application of the 1, 4-polyisoprene dispersion system and the pharmaceutical active component. The dispersion system keeps stable in a gastric acid environment of mammals, does not separate out 1, 4-polyisoprene clots, has no oral toxicity to mammals, and does not contain sensitizers; and the 1, 4-polyisoprene dispersion system comprises a 1, 4-polyisoprene solution dispersion system and a 1, 4-polyisoprene emulsion dispersion system. The 1, 4-polyisoprene dispersion system provided by the invention can be used as an active pharmaceutical ingredient for preparing drugs for treating chronic metabolic diseases including atherosclerotic cardiovascular and cerebrovascular diseases, type 2 diabetes, hypercholesteremia, hypertriglyceridemia, fatty liver, colitis, obesity and polycystic ovarian syndrome.
Owner:SUZHOU HAIYI BIOMEDICAL TECH CO LTD

Application of CXCL11 as antiviral drug

The invention discloses an application of CXCL11 as an antiviral drug, relates to the field of biological medicines, and in particular relates to a protein of an antiviral drug, and the protein as the antiviral drug can inhibit infection and replication of RSV (Respiratory Syndrome Virus). The invention also provides a technical enlightenment for taking a related host protein in a virus infection pathway as an antiviral drug research target, and an application related indication of the CXCL11 protein analogue to clinical symptoms and / or clinical indications caused by severe respiratory syncytial virus infection. The invention further provides an administration route of the CXCL11 serving as an antiviral drug, a dosage range of drug intervention and the like, and finally, the feasibility of the CXCL11 serving as the antiviral drug is further verified through drug intervention application after drug challenge in CXCL11 <- / -> mice.
Owner:BEIJING CHILDRENS HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Probiotic composition and application thereof in preparation of products for preventing and treating vagina inflammation

According to the probiotic composition and the application of the probiotic composition in preparation of products for preventing and treating vagina inflammation, the probiotic composition composed of lactobacillus gasseri B13.52 and lactobacillus mucus B14.46 screened from vaginal secretion of healthy women can effectively inhibit growth of escherichia coli, gardnerella and prevotella; the secretion of proinflammatory factors in vaginal epithelial cells can be obviously reduced, so that an anti-inflammatory effect is achieved.
Owner:MBIOU

Medicinal patch needle for preventing and treating allergic rhinitis as well as preparation method and application of medicinal patch needle

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a medicine patch needle for preventing and treating allergic rhinitis and a preparation method and application thereof. The medicine patch needle mainly comprises a traditional Chinese medicine composition and a medicine patch thumbtack needle, and the traditional Chinese medicine composition is prepared from, by weight, 30-60 parts of radix astragali, 15-30 parts of radix angelicae sinensis, 10-25 parts of radix saposhnikoviae, 10-30 parts of rhizoma atractylodis, 10-30 parts of rhizoma acori graminei, 5-15 parts of herba asari, 10-30 parts of rhizoma chuanxiong, 10-20 parts of radix angelicae and 1-5 parts of borneol. The medicine needle patch can be used for preventing and treating allergic rhinitis, mild and lasting acupuncture stimulation is achieved on the skin part of the acupoint, the medicine can rapidly enter the acupoint along with the needle hole, in other words, the acupoint achieves the effects of harmonizing qi and blood, relieving stuffy nose and removing pathogenic qi under the dual action of the acupuncture stimulation and the medicine, and the medicine needle patch has the remarkable preventing and treating effect on the allergic rhinitis.
Owner:SHANXI UNIV OF CHINESE MEDICINE

Application of reagent for promoting expression of miR-15b-5p in preparation of medicine for promoting muscle injury repair

The invention belongs to the technical field of biological medicines, and particularly relates to application of a reagent for promoting expression of miR-15b-5p in preparation of a medicine for promoting muscle injury repair, the nucleotide sequence of the miR-15b-5p is TAGCAGCACATCGGTTTACA, and the nucleotide sequence is marked as SEQ ID NO.1. The invention also relates to application of the reagent for promoting expression of the miR-15b-5p in preparation of a medicine for promoting muscle injury repair. Through miR-15b-5p overexpression and knock-down experiments, the overexpression of the miR-15b-5p can extremely remarkably inhibit the expression of a proliferation gene of a C2C12 cell and extremely remarkably inhibit the cell activity, the miR-15b-5p can promote the apoptosis of the C2C12 cell, and meanwhile, the overexpression of the miR-15b-5p can promote the differentiation of the C2C12 cell.
Owner:SICHUAN AGRI UNIV

Traditional Chinese medicine composition for treating gastroesophageal reflux cough and pharmaceutical preparation and application thereof

PendingCN118987154Alung and stomachCough goes away on its ownOrganic active ingredientsHeavy metal active ingredientsFormularyFritillaria thunbergii
The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating gastroesophageal reflux cough and a pharmaceutical preparation and application thereof. The traditional Chinese medicine composition is prepared from, by weight, 3-6 parts of rhizoma coptidis, 3-6 parts of fructus evodiae, 10-20 parts of inula pedunculata, 15-25 parts of ruddle, 10-20 parts of fructus aurantii, 10-20 parts of rhizoma pinelliae, 5-10 parts of pericarpium citri reticulatae, 3-6 parts of fresh ginger, 10-20 parts of radix glehniae, 10-20 parts of radix scutellariae, 10-20 parts of bulbus fritillariae thunbergii and 20-30 parts of concha meretricis seu cyclinae. Pharmacodynamic experiments prove that the traditional Chinese medicine composition formula provided by the invention can effectively inhibit reflux, reduce the occurrence of airway neurogenic inflammation, improve respiratory tract inflammatory response and achieve the purpose of treating gastroesophageal reflux cough, the clinical effect is affirmative, no obvious adverse reaction is found, and the traditional Chinese medicine composition has a remarkable new medicine transformation application prospect.
Owner:YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE

Fish scale collagen skin care composition, fish scale collagen cosmetic and preparation method of fish scale collagen skin care composition and fish scale collagen cosmetic

The invention discloses a fish scale collagen skincare composition, a fish scale collagen cosmetic and a preparation method of the fish scale collagen skincare composition and the fish scale collagen cosmetic. The fish scale collagen skincare composition comprises 0.05-0.5 part of fish scale collagen, 0.05-0.5 part of madecassoside and 0.5-3 parts of a purslane extract. According to the invention, the fish scale collagen, madecassoside and purslane extract are combined to repair the skin barrier, calm and relieve nerves, relieve skin inflammatory response and improve sensitive skin in multiple aspects from the aspects of sensitive skin characteristics, possible mechanisms and the like instead of treating head pain and foot pain. The fish scale collagen, madecassoside and purslane extract are derived from fish scales, centella asiatica and purslane of perches respectively, are gifts given to human beings by the nature, are green and healthy, and can endow the perches with high economic value, and through the simple synergistic effect of the three components and the extremely small component addition amount, the basic state of the skin of sensitive skin is consolidated, and the skin care effect is improved. The symptoms of itching, redness and the like after the sensitive skin is stimulated are relieved.
Owner:HANGZHOU SINGCLEAN MEDICAL PROD

Frozen 3D printing stent with synergistic signal molecules as well as preparation method and application of frozen 3D printing stent

The invention belongs to the field of bone tissue engineering, and particularly relates to a frozen 3D printing stent with synergistic signal molecules and a preparation method and application thereof.The ink composition with the synergistic signal molecules comprises a first porous carrier loaded with CO molecule prodrugs and a second porous carrier loaded with NO molecule prodrugs, the surface of the first porous carrier is coated with a first encapsulation layer, the first encapsulation layer is used for blocking the CO molecule prodrug in pores of the first porous carrier, and the first encapsulation layer can be self-degraded and release CO molecules under the condition of high oxygen activity; the surface of the second porous carrier is coated with a second encapsulation layer, the second encapsulation layer is used for blocking the NO molecule prodrug in pores of the second porous carrier, and the second encapsulation layer can be self-degraded and release NO molecules under an acidic condition. By means of the method, the stent which is complete in structure, capable of achieving timely vascularization and capable of stabilizing osteogenesis can be obtained.
Owner:FUJIAN INST OF RES ON THE STRUCTURE OF MATTER CHINESE ACAD OF SCI

Application of Z-IEED-FMK in preparation of medicine for treating acne vulgaris

The invention discloses an application of Z-ITED-FMK in preparation of a medicine for treating acne vulgaris, the Z-ITED-FMK can relieve auricle skin lesion of a mouse acne model, reduce auricle skin thickness, improve inflammatory response and reduce C.acnes titer, the Z-ITED-FMK has a treatment effect on AV, and the Z-ITED-FMK inhibits the inflammatory response of acne local skin and reduces the titer of C.acnes in the skin.
Owner:NANTONG UNIV

Dietary nutrition supplement for regulating glycometabolism based on green tea cell wall polysaccharide and tea polyphenol and application of dietary nutrition supplement

The invention relates to a dietary nutrition supplement for regulating sugar metabolism based on green tea cell wall polysaccharide and tea polyphenol and application of the dietary nutrition supplement for regulating sugar metabolism based on green tea cell wall polysaccharide and tea polyphenol, the active ingredients of the dietary nutrition supplement for regulating sugar metabolism based on green tea cell wall polysaccharide and tea polyphenol comprise green tea cell wall polysaccharide and tea polyphenol, the mass ratio of the green tea cell wall polysaccharide to the tea polyphenol is (1: 3)-(3: 1). The invention further discloses application of the dietary nutrition supplement or a preparation containing the dietary nutrition supplement in preparation of drugs and health care products for regulating glycolipid metabolism. Compared with the prior art, the dietary nutrition supplement provided by the invention can regulate glycolipid metabolism, reduce oxidative stress and improve body inflammatory response, and has a good application prospect in hyperglycemia / diabetes patient groups.
Owner:SHANGHAI JIAOTONG UNIV +1

Circumcision fixing support

The utility model discloses a circumcision fixing support which solves the technical problems that in the operation process of circumcision, a large amount of wound subcutaneous tissue is exposed, the exposure time is long, the wound infection probability is increased, postoperative wound involution is poor, wound healing is slow due to many foreign matter inflammatory reactions, and pain is caused by removal of wound fixtures. The prepuce fixing device comprises an inner ring sleeved on the coronary sulcus of the penis, an elastic thread matched with the inner ring and used for fixing the prepuce at an operation part, and a support sleeved outside a prepuce wound and used for fixing an absorbable suture at a wound suture part, the stent comprises a plurality of stent sections which are arranged on the absorbable suture in a penetrating manner. The device is simple in structure, reasonable in design, simple in surgical operation, and few in wound suture knots; less wound subcutaneous tissue is exposed, the exposure time is short, and the wound infection probability is effectively reduced; the wound is fixed by the support after operation, so that wound contracture is avoided; suture removal is completely avoided after operation, and slow wound healing caused by inflammatory reaction due to many foreign matters on the wound is avoided.
Owner:段有才

Medicine for treating metabolism-related fatty liver disease by taking JOSD2 gene or protein as target spot

The invention discloses a medicine for treating metabolism-related fatty liver diseases by taking a JOSD2 gene or protein as a target spot, and belongs to the technical field of biological medicines. The medicine contains a substance for up-regulating JOSD2 gene expression or enhancing a JOSD2 protein function. The new functions of the JOSD2 gene and the encoded protein thereof in MAFLD are confirmed through in-vivo and in-vitro experiments for the first time, it is determined that JOSD2 is a protection factor in MAFLD, MAFLD can be treated by increasing JOSD2 expression or enhancing the activity of JOSD2, and MAFLD treatment drugs are developed by taking JOSD2 as a drug action target. The invention provides a brand new target for clinical treatment of MAFLD, and provides a new thought and a new view for innovative drug research and development of MAFLD.
Owner:ZHEJIANG UNIV

Application of physcion in preparation of analgesic product

The invention discloses an application of physcion in preparation of analgesic products. The emodin monomethyl ether is used as a single active component, the pain relieving mechanism of the emodin monomethyl ether is deeply discussed, and it is proved that the emodin monomethyl ether can be used as a TRPV1 activity regulator, and expression of TRPV1 is effectively inhibited. Experiments find that the physcion can effectively reduce the twisting frequency of mice caused by acid, significantly increase the pain threshold value of the mice in a hot plate experiment and a CFA inflammatory pain experiment, show an effect of enhancing the pain resistance to heat and inflammation stimulation, and meanwhile, have a significant effect of relieving metastatic bone cancer pain of the mice. The physcion shows a remarkable analgesic effect on animals, and safety or toxic and side effects are not observed.
Owner:SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY

A postoperative auxiliary comprehensive treatment system with space-time response and a preparation method and application thereof

ActiveCN121221785Bplay an anti-inflammatory roleImprove the immune microenvironmentImmunomodulating AgentCombined treatment
The application discloses a postoperative auxiliary comprehensive treatment system with spatiotemporal response and a preparation method and application thereof, and relates to the fields of biology and medicine and the technical field of pharmaceutical preparations. The system comprises a temperature-sensitive hydrogel matrix, an anti-inflammatory drug dispersed in the hydrogel matrix, and nanoparticles loaded with an immunomodulator and dispersed in the hydrogel matrix. In an embodiment of the application, a postoperative auxiliary treatment comprehensive system is successfully constructed, and curcumin and MPDA encapsulating R848 are simultaneously loaded in the gel support. The small molecule curcumin is preferentially released from the gel to play an anti-inflammatory role, and R848 needs to be gradually released from the mesopore of the MPDA and the gel, so that the immune microenvironment can be improved after the anti-inflammatory curcumin promotes wound healing.
Owner:QINGDAO UNIV

A diagnostic system for chronic liver fibrosis

The purpose of the present invention is to achieve quantification and reliable diagnosis of liver fibrosis, and provides a diagnostic system for chronic liver fibrosis disease, which is used for diagnosing or assisting in the diagnosis of the degree of chronic liver fibrosis, and is characterized in that the diagnosis result is obtained by detecting the tertiary lymphatic structure in the patient's liver, including: an image forming device, which is used to image the patient's liver tissue staining sample to obtain a sample image; an image analyzing device, which is used to analyze the sample image to obtain the analysis result of the tertiary lymphatic structure in the patient's liver, and further obtain the diagnosis result based on the tertiary lymphatic structure analysis result.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Application of USP53 gene silencing drugs in renal ischemia-reperfusion injury

The present invention belongs to the field of biological gene engineering technology, and relates to an application of silencing USP53 gene in a drug for renal ischemia-reperfusion injury. The present invention proposes the application of a substance for silencing USP53 expression in human renal tubular epithelial cells in a drug for alleviating the inflammatory response, apoptosis and ferroptosis of renal tubular cells induced by renal ischemia-reperfusion. The above-mentioned substance for silencing USP53 expression in human renal tubular epithelial cells includes a small interfering RNA with a sequence of GUGCGGUACAUUUCUACAATT. The present invention discloses for the first time that silencing USP53 expression in renal tubular epithelial cells can improve renal ischemia-reperfusion injury, and provides a new drug design target for the treatment of renal ischemia-reperfusion injury, which has important theoretical guidance and clinical transformation application value.
Owner:THE SECOND HOSPITAL OF SHANDONG UNIV

Application of blood flow interruption in the preparation of medicine for treating ulcerative colitis

The present invention relates to the field of medical technology, and specifically to an application of blood flow interruption in the preparation of a drug for treating ulcerative colitis. The present invention uses blood flow interruption to treat ulcerative colitis, which can effectively reduce the DAI score, inhibit the level of inflammatory factors in plasma, reduce the inflammatory response of colon mucosal tissue, play a protective role on the colon mucosa, and thus achieve its therapeutic effect, and has broad application prospects.
Owner:SHENYANG PHARMA UNIV

Ginseng peptide food preparation capable of reducing skin inflammation

The invention relates to a ginseng peptide food preparation capable of reducing skin inflammation. The ginseng peptide food preparation comprises ginseng peptide with an amino acid sequence as shown in SEQ ID NO: 1. The ginseng peptide monomer and the ginseng peptide food preparation separated and purified by the method can regulate the immune system of a body, have a relatively obvious inflammation inhibition effect, can inhibit the skin inflammation of a psoriasis mouse, and have the potential of further turning to medicines.
Owner:SHANGHAI YUESHUAI PURE BIOTECHNOLOGY CO LTD

Paeonia suffruticosa collagen polypeptide composition for tightening and resisting wrinkles and preparation method thereof

The invention relates to the field of external skin care products, in particular to a peony collagen polypeptide composition for tightening and resisting wrinkles and a preparation method of the peony collagen polypeptide composition. The peony collagen polypeptide composition for tightening and resisting wrinkles is prepared from the following components in percentage by mass: 1 to 3 percent of peony root extract, 10 to 20 percent of polypeptide mixture, peony flower water, 0.3 to 0.6 percent of soluble collagen, 0.1 to 0.5 percent of ganoderma sinensis extract, 0.5 to 2 percent of white truffle fungus extract and 0.5 to 2 percent of lalang grass rhizome extract. The invention has the advantages of enhancing the firming and anti-wrinkle effects, improving the tolerance and the like.
Owner:GUANGZHOU MINGMEN GUIXIU BIOTECHNOLOGY CO LTD